EMA panel recommends Lilly’s Mounjaro to children 10 years and older
The European Medicine Agency's Committee for Medicinal Products for Human Use ("CHMP") is recommending that use of Eli...
Tag: LLY
Top FDA brass said to have pushed for a faster review of Lilly’s weight loss pill
Top officials at the U.S. FDA have internally urged its reviewers to speed up the evaluation of Eli Lilly’s (LLY)...
Market Voices: Lilly’s new obesity drug, Bessent, EQT’s robotics move
Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks....
Lilly rises on “best-in-class” data for new weight loss therapy
Eli Lilly (LLY) shares spiked ~3% on Thursday after the obesity drugmaker posted Phase 3 data showing its next-gen therapy...
Lilly succeeds in late-stage trial for next-gen weight loss therapy
Eli Lilly (LLY) announced on Thursday that a late-stage trial for its next-generation weight loss candidate, retatrutide,...
Eli Lilly ends in green after nine consecutive sessions of decline
Eli Lilly (LLY) snapped nine straight sessions of losses on Wednesday after its shares settled 1.16% higher at $993.64. The...
Eli Lilly acquisition rumors reportedly fuel Abivax rally
Shares of French biotech Abivax (ABVX) climbed in Paris on Wednesday, in a move Reuters attributed to market speculation...
Eli Lilly to build $6B API manufacturing plant in Alabama
Eli Lilly (LLY) has announced plans to spend $6B to construct a facility to produce active pharmaceutical ingredients in...
Eli Lilly completes acquisition of Adverum Biotechnologies
Eli Lilly (LLY) has completed its acquisition of Adverum Biotechnologies (ADVM), and with it, gains the gene therapy...
Lilly’s Jaypirca succeeds in late-stage trial as a first-line option in lymphoma
Eli Lilly (LLY) announced on Tuesday that its Bruton tyrosine kinase inhibitor Jaypirca (pirtobrutinib) reached the main...